News Articles Tagged: MTH1 Inhibitors

The Scientific Frontier: 2-Chloro-4-phenylquinazoline in MTH1 Inhibitor Development

Explore the cutting-edge research utilizing 2-Chloro-4-phenylquinazoline (CAS 29874-83-7) for the development of MTH1 inhibitors as potential cancer eradicators.

Unlocking Cancer Therapies: The Role of 2-Chloro-4-phenylquinazoline in MTH1 Inhibitor Synthesis

Explore how 2-Chloro-4-phenylquinazoline (CAS 29874-83-7) serves as a critical intermediate in the synthesis of MTH1 inhibitors, offering new avenues for cancer eradication research.